Akorn (AKRX) Bullish Stance Reiterated at Jefferies as Competitor's Generic Fails to Gain Traction
Tweet Send to a Friend
Jefferies analyst David Steinberg reiterated a Buy rating and $56 price target on Akorn (NASDAQ: AKRX) saying Actavis (NYSE: ACT) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
